We only have this paper's title and publication details.
Read it at the sourceCommentary evaluates CYP3A5 pharmacogenomic-guided tacrolimus dosing alongside azole antifungals in lung transplant recipients, highlighting challenges in predicting drug exposure.
We read with
No takes yet. Share an insight, caveat, or question.
Pandey et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: